Skip to main navigation Skip to search Skip to main content

Cross-reactivity of glycan-reactive HIV-1 broadly neutralizing antibodies with parasite glycans

  • Isabella Huettner
  • , Stefanie A. Krumm
  • , Sonia Serna
  • , Katarzyna Brzezicka
  • , Serena Monaco
  • , Samuel Walpole
  • , Angela Van Diepen
  • , Fiona Allan
  • , Thomas Hicks
  • , Simon Kimuda
  • , Aidan M. Emery
  • , The IAVI Protocol C Investigators & The IAVI African HIV Research Network
  • , Susan Allen
  • , William Kilembe
  • , Shabir Lakhi
  • , Mubiana Inambao
  • , Etienne Karita
  • , Anatoli Kamali
  • , Eduard J. Sanders
  • , Omu Anzala
  • Vinodh Edward, Linda-Gail Bekker, Jianming Tang, Jill Gilmour, Eric Hunter, Matt Price, Elise Landais, Cornelis H. Hokke, Jesus Angulo, Niels Reichardt, Katie J. Doores

    Research output: Contribution to journalArticlepeer-review

    5 Citations (Scopus)
    20 Downloads (Pure)

    Abstract

    The HIV-1 Envelope glycoprotein (Env) is the sole target for broadly neutralizing antibodies (bnAbs). Env is heavily glycosylated with host-derived N-glycans, and many bnAbs bind to, or are dependent upon, Env glycans for neutralization. Although glycan-binding bnAbs are frequently detected in HIV-infected individuals, attempts to elicit them have been unsuccessful because of the poor immunogenicity of Env N-glycans. Here, we report cross-reactivity of glycan-binding bnAbs with self- and non-self N-glycans and glycoprotein antigens from different life-stages of Schistosoma mansoni. Using the IAVI Protocol C HIV infection cohort, we examine the relationship between S. mansoni seropositivity and development of bnAbs targeting glycan-dependent epitopes. We show that the unmutated common ancestor of the N332/V3-specific bnAb lineage PCDN76, isolated from an HIV-infected donor with S. mansoni seropositivity, binds to S. mansoni cercariae while lacking reactivity to gp120. Overall, these results present a strategy for elicitation of glycan-reactive bnAbs which could be exploited in HIV-1 vaccine development.
    Original languageEnglish
    Article number110611
    JournalCell Reports
    Volume38
    Issue number13
    DOIs
    Publication statusPublished - 29 Mar 2022

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Keywords

    • CP: Immunology
    • HIV-1
    • Schisotosoma mansoni
    • glycan epitope
    • neutralizing antibody
    • vaccine

    Cite this